BAUDAX BIO, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.01 USD | +25.00% |
|
+25.00% | -54.55% |
| 22/02 | Baudax Bio, Inc. Filed for Bankruptcy | CI |
| 2023 | Baudax Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BAUDAX BIO, INC. | Other Biotechnology & Medical Research | +25.00% | +25.00% | -54.55% | -98.08% | - | 525K |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- BXRXQ Stock
- Charts Baudax Bio, Inc.
- Comparison Chart
